Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01216540 · ClinicalTrials.gov registry record
Vancomycin-Associated Nephrotoxicity
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 398
- Enrollment target
NCT01216540 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 398 participants.
The verdict
NCT01216540 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 398 participants
- Enrollment target
Study Summary
The primary goal of this study is to determine if there is an association between greater exposure to vancomycin and the development of nephrotoxicity. The secondary goal is to estimate the costs to the hospital associated with these nephrotoxic events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01216540
The ClinicalTrials.gov registry entry for NCT01216540 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 398 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01216540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01216540 about?
NCT01216540 is a clinical study titled "Vancomycin-Associated Nephrotoxicity". The primary goal of this study is to determine if there is an association between greater exposure to vancomycin and the development of nephrotoxicity. The secondary goal is to estimate the costs to the hospital associated with these nephrotoxic events.
What is the current status of trial NCT01216540?
This trial is currently completed. The enrollment target is 398 participants. The study started on 2010-11. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT01216540?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.